Use of tofacitinib in recalcitrant cases of chronic pruritus of unknown origin

  • Arch Dermatol Res. 2023 Dec;315(10):2955-2957. doi: 10.1007/s00403-023-02707-1.
Kabir Sardana  1 ,  Savitha Sharath  2 ,  Ananta Khurana  2
Affiliations
  • 1. Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Research Institute and Dr. Ram Manohar Lohia Hospital, New Delhi, India. [email protected].
  • 2. Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Research Institute and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
PMID: 37644139 DOI: 10.1007/s00403-023-02707-1
Keywords
Chronic pruritus; Eosinophils; IL13; IL4; Immunoglobulin E; JAK; Therapy; Tofacitinib.